#USA #Brain Injury #Canary Speech #NeuroLexIQ #Provo, Utah; Knoxville, Tennessee

Introduction

In a groundbreaking collaboration, NeuroLexIQ and Canary Speech are set to transform the personal injury intake process by integrating cutting-edge AI voice analysis technology. This partnership aims to detect potential concussions during the initial stages of client interactions, a game-changer for legal professionals handling personal injury cases.

The Need for Enhanced Detection

Mild traumatic brain injuries (mTBIs) are frequently overlooked in personal injury litigation. Many individuals exit accidents—be it from car collisions or falls—without realizing they have sustained concussions. Without prompt identification, these injuries can go undetected for extended periods, complicating legal claims and hindering evidence collection. This collaboration seeks to address such gaps by providing attorneys with crucial insights right from the first client call.

The Power of Voice Analysis

By embedding Canary Speech's vocal biomarker technology into NeuroLexIQ's Concussion Probability Report, the partnership allows for seamless screening for brain injuries. During structured intake conversations, typically preceding any medical evaluations, the platform leverages AI to analyze minute changes in a client's speech, generating a Concussion Probability Report. This report acts as an objective marker that flags potential injuries, thus facilitating further assessments through qEEG validation, a process that confirms voice-derived signals with FDA-approved neurodiagnostic data.

Early Identification Benefits

The integration of voice analysis into the intake workflow means attorneys can obtain a reliable indication of a client's potential brain injury from the very outset of the case. This development shifts the reliance from subjective symptom reporting—often prone to fading or being mischaracterized—to an objective signal, backed by real-time analysis. For clients, this new process offers a quicker, less intrusive pathway toward identifying whether further medical evaluations are necessary.

Insights from Company Leaders

Henry O'Connell, CEO of Canary Speech, emphasizes the urgency and importance of timely intervention: "For the past decade, we have focused on converting voice signals into clinically significant indicators. In personal injury cases, the speed of analysis is critical. Our partnership with NeuroLexIQ allows us to employ these insights precisely when they are most beneficial."

Mark Slaughter, Founder and CEO of NeuroLexIQ, echoes this sentiment, noting the importance of objective data in personal injury claims: "Incorporating Canary Speech's voice analysis into our intake framework enables us to detect potential brain injuries from the first conversation, ensuring that cases suitable for qEEG testing are identified early before symptoms diminish. This is a meaningful advancement in documentation and support for our clients."

Implementation Timeline

The pilot program for the integrated intake process will commence on July 1, 2026, granting personal injury attorneys early access to this innovative voice-and-EEG workflow. This pilot will test the effectiveness of the AI-driven approach in identifying brain injuries during client intake.

About NeuroLexIQ

NeuroLexIQ, known as The Brain Injury Authority, is dedicated to offering evidence-based support for attorneys engaged in potential brain injury assessments. Through structured screening, mobile EEG diagnostics, and neurologist-reviewed reports, they aim to enhance clarity around concussion cases. Their Concussion Probability Report evaluates symptoms, crash dynamics, and exposure to assess whether further investigation is warranted, providing invaluable support for legal professionals.

About Canary Speech

Located in Utah, Canary Speech specializes in AI-driven voice biomarker technology, utilizing real-time vocal analysis to identify various mental health and neurological disorders. Their technology quickly assesses speech patterns to spot changes in behavioral and cognitive health, often before traditional clinical symptoms manifest. Their latest solution, Canary Ambient™, enables real-time voice analysis in medical environments, offering actionable insights to healthcare providers.

Conclusion

As NeuroLexIQ and Canary Speech embark on this innovative partnership, they are not just enhancing how personal injury claims are processed but also paving the way for clinical advancements in how brain injuries are identified and documented. This collaboration signifies a monumental shift in the landscape of personal injury law, putting objective analysis at the forefront of legal proceedings.